Cetera Advisors LLC Ab Cellera Biologics Inc. Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.29 - $5.97 $827 - $1,152	-193 Reduced 0.85%	22,445 $101,000
Q4 2023 Feb 13, 2024	BUY	$3.91 - $5.93 $6,537 - $9,914	1,672 Added 7.97%	22,638 $129,000
Q3 2023 Nov 14, 2023	BUY	$4.6 - $7.95 $21,569 - $37,277	4,689 Added 28.81%	20,966 $96,000
Q2 2023 Aug 09, 2023	BUY	$5.66 - $7.59 $30,665 - $41,122	5,418 Added 49.89%	16,277 $105,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $20,387 - $31,181	-2,789 Reduced 20.44%	10,859 $81,000
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $129,383 - $198,168	13,648 New	13,648 $138,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.